These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8125830)

  • 1. Towards the ideal glycopeptide.
    Felmingham D
    J Antimicrob Chemother; 1993 Nov; 32(5):663-6. PubMed ID: 8125830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Resistance to glycopeptide antibiotics].
    Trenin AS
    Antibiot Khimioter; 1996 May; 41(5):49-60. PubMed ID: 9054319
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glycopeptide antibiotics resistance mechanism as the basis for novel derivatives development capable to overcome resistance].
    Trenin AS; Olsuf'eva EN
    Bioorg Khim; 1997 Nov; 23(11):851-67. PubMed ID: 9518425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of glycopeptide resistance in clinical isolates of gram-positive bacteria.
    Harding I; Lockett A; Brown E
    J Antimicrob Chemother; 1992 Jul; 30(1):105-8. PubMed ID: 1429329
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.
    Henson KE; Levine MT; Wong EA; Levine DP
    Expert Rev Anti Infect Ther; 2015; 13(10):1265-78. PubMed ID: 26165756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the use in animals of antimicrobial agents, including glycopeptide antibiotics, influence the efficacy of antimicrobial therapy in humans?
    Donnelly JP; Voss A; Witte W; Murray BE
    J Antimicrob Chemother; 1996 Feb; 37(2):389-92. PubMed ID: 8707753
    [No Abstract]   [Full Text] [Related]  

  • 7. [Resistance to glycopeptide antibiotics. New horizons and problems].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2001; 46(6):3-5. PubMed ID: 11573322
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycopeptide-resistant enterococci: a decade of experience.
    Woodford N
    J Med Microbiol; 1998 Oct; 47(10):849-62. PubMed ID: 9788808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-infectious activity of non-antibiotic drugs and their interactions with antibiotics.
    Neuman M
    G Ital Chemioter; 1991; 38(1-3):35-7. PubMed ID: 1365603
    [No Abstract]   [Full Text] [Related]  

  • 10. Oritavancin. Eli Lilly & Co.
    Barrett JF
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1039-44. PubMed ID: 11892911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of increasing glycopeptide MICs against Staphylococcus aureus.
    Gould IM
    Int J Antimicrob Agents; 2008 Apr; 31 Suppl 2():1-9. PubMed ID: 18485997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular and epidemiologic aspects of the resistance to antibiotics: example of glycopeptides on enterococci].
    Courvalin P
    C R Seances Soc Biol Fil; 1996; 190(4):467-9. PubMed ID: 8952897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-synthetic glycopeptide antibacterials.
    Judice JK; Pace JL
    Bioorg Med Chem Lett; 2003 Dec; 13(23):4165-8. PubMed ID: 14622994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Lactam and glycopeptide antibiotics: first and last line of defense?
    Jovetic S; Zhu Y; Marcone GL; Marinelli F; Tramper J
    Trends Biotechnol; 2010 Dec; 28(12):596-604. PubMed ID: 20970210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of bacterial resistance to antimicrobial agents.
    McManus MC
    Am J Health Syst Pharm; 1997 Jun; 54(12):1420-33; quiz 1444-6. PubMed ID: 9194989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycopeptide-resistant Enterococcus faecium outside Hospitals: a commentary.
    Witte W; Klare I
    Microb Drug Resist; 1995; 1(3):259-63. PubMed ID: 9158785
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycopeptide-resistant enterococci in Northern Ireland: first reported outbreak.
    Rizkalla EA; Moore JE; Marshall SA; Murphy PG
    J Antimicrob Chemother; 1997 Oct; 40(4):607-8. PubMed ID: 9372439
    [No Abstract]   [Full Text] [Related]  

  • 18. Newer glycopeptide antibiotics tested against nosocomial bloodstream isolates.
    Buschelman BJ; Jones RN
    J Antimicrob Chemother; 1993 Mar; 31(3):445-7. PubMed ID: 8486582
    [No Abstract]   [Full Text] [Related]  

  • 19. Microbiological properties of teicoplanin.
    Greenwood D
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ramoplanin. A 16686, a 16686a, MDL 62198.
    Drugs R D; 2002; 3(1):61-4. PubMed ID: 11881535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.